Background. The aim of this study was to assess the development of dys
plasia or cancer in patients with ulcerative colitis and to determine
the effectiveness of colonoscopy and biopsy follow-up in colon cancer
surveillance. Methods. From 1980 to 1986, 65 patients who had ulcerati
ve colitis for 7 years or more participated in a surveillance program
of colonoscopy and biopsy. This cohort was followed until December 199
2. Forty-nine patients (75.4%) had extensive colitis and 16 (24.6%) le
ft-sided colitis. The mean disease duration was 17.2 years. Three hund
red four colonoscopies were performed. During each endoscopy, random b
iopsies were performed. Results. Seven patients had definite dysplasia
of the colorectal mucosa. Four of them had high grade lesions and und
erwent surgery. In all of these patients, colon cancer (3 Dukes' Stage
A, 1 Dukes' Stage B) was found. No cancer was found in the other pati
ents. Pedunculated adenomas were excised from 6 other patients during
colonoscopy. When dysplasia was diagnosed, these patients were older t
han those who were dysplasia free, whereas the age at onset of colitis
was significantly higher in the former (P < 0.01). Fifteen patients d
iscontinued follow-up. Two of them developed colon cancer diagnosed at
an advanced stage. Conclusions. Dysplasia, especially of high grade,
is a marker of colon cancer risk in patients with longstanding ulcerat
ive colitis. Intensive colonoscopy and biopsy surveillance can lead to
the diagnosis of colon cancer at a potentially curable stage. In this
series, older age appeared to be an additional risk factor. A careful
selection of patients with ulcerative colitis seems mandatory to mini
mize the cost and optimize the benefit of colon cancer surveillance pr
ograms.